Monroe Capital (NASDAQ:MRCC) Cut to “Hold” at StockNews.com

StockNews.com downgraded shares of Monroe Capital (NASDAQ:MRCC) from a buy rating to a hold rating in a research report released on Monday.

Separately, B. Riley downgraded Monroe Capital from a “neutral” rating to a “sell” rating and set a $7.25 price objective on the stock. in a report on Wednesday, December 11th.

Monroe Capital Stock Up 0.5 %

Shares of Monroe Capital stock opened at $8.18 on Monday. The company has a debt-to-equity ratio of 1.49, a current ratio of 4.37 and a quick ratio of 4.37. Monroe Capital has a 1-year low of $6.97 and a 1-year high of $8.85. The business has a 50-day moving average of $8.51 and a 200-day moving average of $8.25. The company has a market capitalization of $177.23 million, a PE ratio of 13.63 and a beta of 1.03.

Monroe Capital Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be given a dividend of $0.25 per share. The ex-dividend date is Friday, March 14th. This represents a $1.00 annualized dividend and a dividend yield of 12.22%. Monroe Capital’s payout ratio is 166.67%.

Institutional Trading of Monroe Capital

Several hedge funds and other institutional investors have recently bought and sold shares of the company. CIBC Private Wealth Group LLC lifted its holdings in Monroe Capital by 166.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 10,854 shares of the financial services provider’s stock worth $92,000 after buying an additional 6,773 shares during the last quarter. Private Advisor Group LLC bought a new position in Monroe Capital during the third quarter worth $104,000. Envestnet Asset Management Inc. boosted its holdings in Monroe Capital by 13.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 12,688 shares of the financial services provider’s stock worth $108,000 after purchasing an additional 1,486 shares during the period. Aspiriant LLC increased its stake in Monroe Capital by 18.2% during the fourth quarter. Aspiriant LLC now owns 13,000 shares of the financial services provider’s stock valued at $110,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Strategic Financial Concepts LLC acquired a new stake in shares of Monroe Capital during the fourth quarter worth $144,000.

Monroe Capital Company Profile

Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants.